EMFAT
KYNB

Emerald Mutual Fund Advisers Trust’s Kyntra Bio KYNB Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,355
Closed -$15.7M – 219
2018
Q3 		$15.7M Sell
10,355
-2,426
-19% -$3.74M 0.53% 73
2018
Q2 		$20M Buy
+12,781
New +$16.7M 0.72% 44

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's KYNB Position: Q4 2018 in Review

Emerald Mutual Fund Advisers Trust sold out of Kyntra Bio (KYNB) in Q4 2018, closing a stake of 10,355 shares — an estimated $15.7M sold.

Emerald Mutual Fund Advisers Trust first reported a position in KYNB in Q2 2018 and held it in 2 quarters. The position peaked at $20M in Q2 2018. 201 funds tracked by Wall St. Rank hold KYNB as of Q4 2018.

  • Emerald Mutual Fund Advisers Trust reported no remaining Kyntra Bio position as of Q4 2018 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 10,355 Kyntra Bio shares in Q4 2018, an estimated $15.7M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Kyntra Bio in Q2 2018 and held it in 2 quarters.
  • Emerald Mutual Fund Advisers Trust's Kyntra Bio position peaked at $20M in Q2 2018.
  • 201 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2018.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2018, filed 30 Jan 2019.